Story perspectives

Eli Lilly Invests $5 Billion in Virginia Manufacturing Facility

9/16/2025

Summary

Story summary

Eli Lilly plans to invest $5 billion in a manufacturing facility in Goochland County, Virginia, to boost domestic production of cancer and autoimmune treatments.
This facility is part of a $27 billion initiative for four new U.S. plants, expected to be completed in five years.
The investment will generate over 650 permanent jobs and 1,800 construction jobs.
The Virginia site will specialize in active pharmaceutical ingredients and antibody-drug conjugates.
Since 2020, Lilly has committed around $50 billion to U.S. capital expansion.

History

Historical Context

The Affordable Care Act, enacted in 2010, aimed to enhance healthcare access in the U.S., prompting significant pharmaceutical investments. Eli Lilly's $5 billion commitment is part of a broader trend, with the company investing around $50 billion since 2020. This aligns with government efforts to boost domestic production of essential medicines, creating over 2,400 jobs in the process.

1 of 2

Story summary

Eli Lilly plans to invest $5 billion in a manufacturing facility in Goochland County, Virginia, to boost domestic production of cancer and autoimmune treatments.
This facility is part of a $27 billion initiative for four new U.S. plants, expected to be completed in five years.
The investment will generate over 650 permanent jobs and 1,800 construction jobs.
The Virginia site will specialize in active pharmaceutical ingredients and antibody-drug conjugates.
Since 2020, Lilly has committed around $50 billion to U.S. capital expansion.

1 / 2